首页 | 官方网站   微博 | 高级检索  
     

卵巢未成熟畸胎瘤43例综合治疗疗效分析
引用本文:王世宣,唐雄志,王常玉,马丁.卵巢未成熟畸胎瘤43例综合治疗疗效分析[J].华中科技大学学报(医学版),2002,31(1):57-59.
作者姓名:王世宣  唐雄志  王常玉  马丁
作者单位:1. 华中科技大学同济医学院附属同济医院妇产科,武汉,430030
2. 广西壮族自治区桂林市第一人民医院妇产科,桂林,541002
基金项目:湖北省自然科学基金资助项目 (No.98J10 1)
摘    要:为探讨不同手术方式及化疗方法对卵巢未成熟畸胎瘤的疗效及相关影响因素,对43例卵巢未成熟畸胎瘤患者进行回顾性分析。手术方式分为:保守性手术(患侧附件、大网膜切除术+盆、腹腔腹膜结节切除术+盆腔淋巴结清扫术)及根治性手术(全子宫、双附件及大网膜切除术_肿瘤细胞减灭术+盆腔淋巴结清扫术)。术后采用VAC(长春新碱,阿霉素,环磷酰胺)方案、BEP(博莱霉素或平阳霉素,足叶乙叉甙,顺铂或卡铂)方案或VBP(长春新碱,博莱霉素或平阳霉素,顺铂或卡铂)方案进行联合化疗。患者5年生存率根治性手术为44.4%,保守性手术为64.0%,差异无显著性。VAC方案与BEP(或VBP)方案的5年生存率分别为33.3%和77.3%(P<0.01)。疗程数≥4患者的5年生存率为73.9%,明显高于疗程数<4患者的38.9%(P<0.05)。认为对于有生育要求的卵巢未成熟畸胎瘤患者,可仅行保守性手术,术后辅以联合化疗。BEP(或VBP)方案对患者长期生存率的改善明显优于VAC方案。术后化疗的疗程数与疗效有关,对长期生存率的影响较明显。

关 键 词:卵巢肿瘤  未成熟畸胎瘤  综合治疗
修稿时间:2000年12月2日

Combined Therapies for 43 Patients with Ovarian Immature Teratoma
Wang Shixuan ,Tang Xiongzhi ,Wang Changyu et al.Combined Therapies for 43 Patients with Ovarian Immature Teratoma[J].Journal of Huazhong University of Science and Technology(Health Sciences),2002,31(1):57-59.
Authors:Wang Shixuan  Tang Xiongzhi  Wang Changyu
Affiliation:Wang Shixuan 1,Tang Xiongzhi 2,Wang Changyu 1 et al 1 Department of Obstetrics and Gynecology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030 2 Department of Obstetr
Abstract:The therapeutic effects of combined therapies for ovarian immature teratoma and relative factors were investigated. From Aug. 1979 to July. 1999, 43 patients with ovarian immature teratoma hospitalized in our department were eligible for retrospective study. Young patients having no child underwent the conservative surgery: remove the involved ovary and the oviduct, omentum, peritoneal metastases, and pelvic lymph nodes. And those who had no desire to have child received radical surgery: including a total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, resection of peritoneal metastases, and removal of pelvic lymph nodes. All the patients received systemic and(or) intra-abdominal chemotherapy after operation. Regimens were VAC (vincristine, adriamycin, cyclophosphomide), VBP (vincristine, bleomycin, cisplatin or carboplatin) and BEP (bleomycin, etoposide, cisplatin or carboplatin). The 5-year-survival rate of the patients receiving conservative surgery was 44.0 %, lower than that (64.0 %) in the patients receiving radical surgery, but the difference was not significant between them (P>0.05). The 5-year-survival rate of the patients treated by BEP (or VBP) was 77.3 %, significantly higher than that (33.3 %) by VAC (P<0.01). The 5-year survival rate of the patients receiving less or more than 4 courses of combined chemotherapy was 38.9 % and 73.9 % respectively (P<0.05). We considered that in young patients having no child, the uterus and contra lateral ovary might be preserved to maintain fertility. BEP (or VBP) are the more effective regimens for ovarian immature teratoma than VAC. The courses of combined chemotherapy also influence the prognosis of the patients with ovarian immature teratoma.
Keywords:ovarian neoplasm  immature teratoma  chemotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号